PRTA
ProthenaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
PRTA vs peer average
42/100
PRTA vs. peer average (D vs. C)
Grade spread
B 1 · C 5 · D 2 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ACIU is the first available peer comparator.
Clinical-stage neurodegeneration company focused on protein-misfolding targets including amyloid beta, tau, alpha-synuclein, and TDP-43, making it one of the closest public platform and disease-biology comparators to Prothena.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PRTA
Prothena
ACIU
AC Immune
Grade
D
D
Momentum
16
46
Value
41
41
Sentiment
82
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ACIU
PRTA / ACIU
Grade Position
Below peers
PRTA vs. peer average (D vs. C)
42/100
Momentum
16
ACIUValue
41
PRTASentiment
82
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PRTA
ACIU is the first peer returned for this comparison set.